Novolog mix 70-30 flexpen 3ML
Ended Awarded
- Contract number
- SPE2DB25FTWL8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,140
Award facts
- Contract value 100% obligated
- $1,140.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,140.42 by the Defense Logistics Agency on September 24, 2025, for the supply of Novolog Mix 70-30 FlexPen 3ML insulin pens. The order, which carries no set-aside designation, is scheduled for completion by September 25, 2025, with performance taking place in Conshohocken, Pennsylvania. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.9 billion contract vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for military health facilities worldwide.
As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its established relationship with the Defense Logistics Agency to deliver essential medications and medical consumables to Department of Defense healthcare sites. The company's robust contract portfolio demonstrates consistent success in securing pharmaceutical delivery orders covering prescription medications, biologics, vaccines, and specialty medical products without specific set-aside designations. This particular delivery order for insulin pens reflects the company's core business of distributing branded pharmaceutical products to federal agencies in support of military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FTWL8?
SPE2DB25FTWL8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FTWL8 worth?
The government has obligated $1,140 on SPE2DB25FTWL8.
Is contract SPE2DB25FTWL8 an order under another contract?
Yes. SPE2DB25FTWL8 is a delivery order under SPE2DB20D6037, an indefinite delivery contract.
Was contract SPE2DB25FTWL8 competed?
The extent of competition for SPE2DB25FTWL8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award